ESC Premium Access

Doxapram is a promising new antiarrhythmic drug for an atrial-specific therapy of atrial fibrillation

Congress Presentation

About the speaker

Professor Constanze Schmidt

University hospital Heidelberg, Heidelberg (Germany)
5 presentations
0 follower

5 more presentations in this session

The incidence, treatment and mortality of new-onset atrial fibrillation patients at the intensive care unit

Speaker: Mrs M. Jacobs (Groningen, NL)


Typical atrial flutter is a manifestation of previously silent coronary artery disease

Speaker: Mr L. Iden (Bad Segeberg, DE)


Pericardial fat volume outperforms classic risk markers in the prediction of relapse after pulmonary vein isolation

Speaker: Doctor J. Carmo (Carnaxide, PT)


Zero-fluoroscopy catheter ablation of right- and left-sided supraventricular tachycardias

Speaker: Doctor M. Jan (Ljubljana, SI)


Pulsed Field Ablation: Acute and Chronic Safety and Lesion Efficacy

Speaker: Doctor A. Verma (Montreal, CA)


Access the full session

Novelties in atrial fibrillation and flutter management

Speakers: Professor C. Schmidt, Mrs M. Jacobs, Mr L. Iden, Doctor J. Carmo, Doctor M. Jan...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb